{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:19:46Z","timestamp":1778656786636,"version":"3.51.4"},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Volunteer infection studies using the induced blood stage malaria (IBSM) model have been shown to facilitate antimalarial drug development. Such studies have traditionally been undertaken in single\u2010dose cohorts, as many as necessary to obtain the dose\u2010response relationship. To enhance ethical and logistic aspects of such studies, and to reduce the number of cohorts needed to establish the dose\u2010response relationship, we undertook a retrospective <jats:italic>in silico<\/jats:italic> analysis of previously accrued data to improve study design. A pharmacokinetic (PK)\/pharmacodynamic (PD) model was developed from initial fictive\u2010cohort data for OZ439 (mixing the data of the three single\u2010dose cohorts as: <jats:italic>n<\/jats:italic>\u00a0=\u00a02 on 100\u00a0mg, 2 on 200\u00a0mg, and 4 on 500\u00a0mg). A three\u2010compartment model described OZ439 PKs. Net growth of parasites was modeled using a Gompertz function and drug\u2010induced parasite death using a Hill function. Parameter estimates for the PK and PD models were comparable for the multidose single\u2010cohort vs. the pooled analysis of all cohorts. Simulations based on the multidose single\u2010cohort design described the complete data from the original IBSM study. The novel design allows for the ascertainment of the PK\/PD relationship early in the study, providing a basis for rational dose selection for subsequent cohorts and studies.<\/jats:p>","DOI":"10.1111\/cts.12934","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T19:44:26Z","timestamp":1608234266000},"page":"712-719","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective Analysis Using Pharmacokinetic\/Pharmacodynamic Modeling and Simulation Offers Improvements in Efficiency of the Design of Volunteer Infection Studies for Antimalarial Drug Development"],"prefix":"10.1111","volume":"14","author":[{"given":"Kayla Ann","family":"Andrews","sequence":"first","affiliation":[{"name":"Cognigen Corporation a SimulationsPlus Company Buffalo New York USA"},{"name":"Department of Pharmaceutical Sciences State University of New York at Buffalo Buffalo New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel S.","family":"Owen","sequence":"additional","affiliation":[{"name":"Cognigen Corporation a SimulationsPlus Company Buffalo New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McCarthy","sequence":"additional","affiliation":[{"name":"The Royal Melbourne Hospital The University of Melbourne at the Doherty Institute Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wesche","sequence":"additional","affiliation":[{"name":"Certara Strategic Consulting Princeton New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Gobeau","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture Geneva Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaddeus H.","family":"Grasela","sequence":"additional","affiliation":[{"name":"Cognigen Corporation a SimulationsPlus Company Buffalo New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg J.","family":"M\u00f6hrle","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture Geneva Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"e_1_2_10_1_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021914"},{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw174"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw128"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1511-3"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02883-15"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12962"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30171-8"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012299115260"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:JOPA.0000012999.36063.4e"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1999-1"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774515626362"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510062"},{"key":"e_1_2_10_13_1","unstructured":"Gottlieb S.RAPS 2017 Regulatory Convergence Conference. Regulatory Affairs Professionals Society; 2017 September 11; Washington DC: FDA;2017."},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04368.x"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.12934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cts.12934","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.12934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T22:26:05Z","timestamp":1693607165000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.12934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1111\/cts.12934"],"URL":"https:\/\/doi.org\/10.1111\/cts.12934","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]},"assertion":[{"value":"2020-07-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}